Telegram
BioNano Genomics WT EXP 082123 BNGOW
$ 0.0
-23.4%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиBioNano Genomics WT EXP 082123 Мультипликаторы 2011-2024 | BNGOW
Мультипликаторы по годам BioNano Genomics WT EXP 082123
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -0.0 | -0.8 | - | - | - | - | - | - | - | - | - | - |
P/S |
- | 0.2 | 3.1 | - | - | - | - | - | - | - | - | - | - |
EPS |
-6.8 | -4.6 | -0.3 | -0.4 | -2.0 | -2.6 | -8.7 | - | - | - | - | - | - |
EV (Enterprise Value) |
100 млн | 58.8 млн | 70.8 млн | -38.4 млн | -17.3 млн | -16.5 млн | - | - | - | - | - | - | - |
EBITDA per Share |
-5.9 | -4.22 | -0.27 | - | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-0.2 | - | - | - | - | - | - | - | - | - | - | ||
PEG |
- | - | - | - | - | - | - | - | - | - | - | ||
P/B |
- | 0.0 | 0.2 | - | - | - | - | - | - | - | - | - | - |
P/CF |
- | -0.0 | -0.8 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-241.78 | -53.17 | -21.49 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-108.44 | -43.12 | -19.21 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-223.85 | -52.81 | -22.87 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.8 | 5.3 | 9.4 | - | - | - | - | - | - | - | - | - | - |
DSO |
82.6 | 78.5 | 78.2 | - | - | - | - | - | - | - | - | - | - |
DIO |
394.3 | 351.9 | 203.1 | - | - | - | - | - | - | - | - | - | - |
DPO |
157.5 | 194.6 | 177.2 | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
476.9 | 430.4 | 281.4 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
319.3 | 235.8 | 104.2 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально BioNano Genomics WT EXP 082123
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-3.22 | -1.24 | -0.12 | - | -1.1 | -1.13 | -0.11 | - | -0.07 | -0.07 | -0.04 | - | -0.08 | -0.09 | -0.3 | - | -0.59 | -0.71 | -0.77 | - | -0.63 | -0.98 | -1.16 | - | -1.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.11 | - | -0.87 | -1.12 | -0.1 | - | -0.07 | -0.06 | -0.04 | - | -0.07 | -0.08 | -0.27 | - | -0.5 | -0.61 | -0.58 | - | -0.72 | -1.08 | -1.19 | - | -1.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-140.04 | -56.74 | -49.91 | -32.21 | -38.29 | -33.07 | -27.21 | -14.25 | -45.01 | -69.70 | -87.28 | -83.74 | -302.39 | -448.66 | -602.68 | -791.32 | -635.91 | -507.47 | -363.10 | -182.46 | -131.00 | -35.89 | -3.22 | 34.73 | 46.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-98.75 | -46.70 | -40.96 | -27.03 | -32.80 | -20.14 | -25.41 | -13.62 | -31.47 | -43.55 | -51.65 | -48.59 | -74.75 | -78.07 | -85.90 | -94.66 | -94.36 | -93.04 | -85.21 | -74.57 | 9.63 | -200.82 | -187.47 | -171.96 | -230.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-141.17 | -57.44 | -50.44 | -32.30 | -38.35 | -33.00 | -26.49 | -13.90 | -43.05 | -66.14 | -82.57 | -78.17 | -235.48 | -363.63 | -531.81 | -517.82 | -576.70 | -478.27 | -328.48 | -141.23 | -131.21 | -62.31 | -22.73 | 10.02 | 10.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.9 | 4.8 | 4.8 | 5.3 | 7.7 | - | 9.4 | 9.4 | 19.9 | 32.6 | 17.4 | 2.4 | 2.4 | 2.4 | 2.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.7 | 1.7 | 1.7 | 1.7 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
79.7 | 75.8 | 84.9 | - | 36.8 | 37.7 | 83.7 | - | 57.2 | 57.1 | 68.7 | - | 115.3 | 214.2 | 365.8 | 207.2 | 174.5 | 265.7 | 267.1 | 102.6 | 145.6 | 121.5 | 202.9 | 107.5 | 55.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
458.2 | 470.8 | 536.7 | - | 211.2 | 142.8 | 270.4 | - | 181.3 | 149.6 | 136.4 | - | 207.2 | 501.8 | 360.3 | 185.9 | 132.3 | 202.1 | 179.5 | 32.6 | 31.8 | 53.8 | 149.8 | 103.3 | 45.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
189.5 | 198.8 | 241.7 | - | 79.3 | 57.8 | 153.7 | - | 151.4 | 112.4 | 110.3 | - | 183.1 | 443.4 | 300.0 | 145.7 | 103.7 | 158.4 | 161.1 | 41.3 | 40.2 | 68.0 | 198.2 | 140.5 | 62.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
537.9 | 546.6 | 621.6 | - | 248.0 | 180.5 | 354.1 | - | 238.4 | 206.8 | 205.0 | - | 322.6 | 716.0 | 726.1 | 393.1 | 306.8 | 467.8 | 446.6 | 135.3 | 177.4 | 175.3 | 352.7 | 210.8 | 101.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
348.4 | 347.8 | 379.9 | - | 168.7 | 122.7 | 200.4 | - | 87.0 | 94.4 | 94.7 | - | 139.4 | 272.6 | 426.1 | 247.4 | 203.1 | 309.5 | 285.5 | 94.0 | 137.2 | 107.3 | 154.6 | 70.3 | 39.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD